Case Report
Copyright ©2010 Baishideng.
World J Gastroenterol. May 28, 2010; 16(20): 2571-2576
Published online May 28, 2010. doi: 10.3748/wjg.v16.i20.2571
Table 1 Reported cases of intrahepatic cholangiocarcinoma clear cell variant
YrAge (yr)/sexLocationSize (cm)HepatitisLiver cirrhosisMechanismPrognosis
1998[10]64/FUnknown12UnknownUnknownUnknownUnknown
1998[11]62/MRight lobe5--UnknownDead, 14 mo; no treatment
1998[7]72/MLeft lobe15UnknownUnknownLipid >> glycogenAlive, 30 mo
1999[8]50/MS61.5-UnknownMucinAlive, 12 mo
2001[9]64/MRight lobe6--UnknownAlive, 3 yr
2007[4]51/MS4a9Unknown-Lipid >> glycogenMeta, 1 yr; dead, 3 yr
2007[4]60/FS54.5Unknown-Lipid >> glycogenAlive, 1 yr
2007[4]58/FS52.3Unknown-Lipid >> glycogenAlive
Present case56/MS72.2HBV-GlycogenAlive, 7 mo
Table 2 Serum data on admission
ItemDataNormal values
HBs-Ag (C.O.I)277.5< 1.0
HBs-Ab (mIU/mL)165.1< 5.0
Anti-HCV-Ab (C.O.I)0.1< 1.0
α-fetoprotein (ng/mL)3.6 ≤ 7.0
PIVKA-II (mAU/mL)17.0< 40.0
Carcinoembryonic antigen (ng/mL)2.4 ≤ 5.0
Total cholesterol (mg/dL)181.0128-25
Aspartate aminotransferase ( IU/L)28.013-33
Alanine aminotransferase (IU/L)21.08-42
Alkaline phosphatase (IU/L)198.0115-359
Lactate dehydrogenase (IU/L)207.0119-229
γ-glutamyl transpeptidase (IU/L)30.010-47
Table 3 Immunohistochemical staining
AntibodyCompanyResult
CK7DAKO+
CK19DAKO+
CK20DAKO-
CAM5.2Becton, Dickinson, and Co.+
EMADAKO+
CA19-9DAKO+ focal
CEADAKO-
CD56DAKO+ focal
AE1/3DAKO+
Ki-67 (MIB-1)Novocastra7.5%1
p53Novocastra+ focal
Bcl-2DAKO-
TTF-1DAKO-
HepatocyteDAKO-
a-FetoproteinDAKO-
VimentinDAKO-
CD10DAKO-
S-100 proteinDAKO-
ChromograninDAKO-
SynaptophysinDAKO-